ITMI911432A1 - Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 alfa reduttasi - Google Patents

Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 alfa reduttasi

Info

Publication number
ITMI911432A1
ITMI911432A1 IT001432A ITMI911432A ITMI911432A1 IT MI911432 A1 ITMI911432 A1 IT MI911432A1 IT 001432 A IT001432 A IT 001432A IT MI911432 A ITMI911432 A IT MI911432A IT MI911432 A1 ITMI911432 A1 IT MI911432A1
Authority
IT
Italy
Prior art keywords
group
chem
hydrogen
alkyl group
cycloalkyl
Prior art date
Application number
IT001432A
Other languages
English (en)
Inventor
Salle Enrico Di
Marcella Nesi
Achille Panzeri
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI911432A0 publication Critical patent/ITMI911432A0/it
Priority to ITMI911432A priority Critical patent/IT1259419B/it
Priority to MYPI92000863A priority patent/MY131089A/en
Priority to YU52992A priority patent/YU52992A/sh
Priority to US07/886,574 priority patent/US5212166A/en
Priority to IL10194792A priority patent/IL101947A/en
Priority to NZ242850A priority patent/NZ242850A/en
Priority to DK92910992.4T priority patent/DK0540717T3/da
Priority to CZ93265A priority patent/CZ281309B6/cs
Priority to AU17781/92A priority patent/AU655280B2/en
Priority to HU9300176A priority patent/HUT64083A/hu
Priority to JP50978992A priority patent/JP3226919B2/ja
Priority to EP92910992A priority patent/EP0540717B1/en
Priority to DE69221074T priority patent/DE69221074T2/de
Priority to AT92910992T priority patent/ATE155792T1/de
Priority to EP92108670A priority patent/EP0517047A1/en
Priority to IDP308292A priority patent/ID954B/id
Priority to PCT/EP1992/001153 priority patent/WO1992020700A1/en
Priority to CA002087953A priority patent/CA2087953A1/en
Priority to ES92910992T priority patent/ES2106185T3/es
Priority to RU93004939A priority patent/RU2104283C1/ru
Priority to MX9202438A priority patent/MX9202438A/es
Priority to ZA923758A priority patent/ZA923758B/xx
Priority to TW081104019A priority patent/TW213467B/zh
Priority to CN92103919A priority patent/CN1035055C/zh
Priority to IE163492A priority patent/IE921634A1/en
Publication of ITMI911432A1 publication Critical patent/ITMI911432A1/it
Priority to FI930277A priority patent/FI930277A/fi
Priority to NO93930244A priority patent/NO930244L/no
Application granted granted Critical
Publication of IT1259419B publication Critical patent/IT1259419B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Details Of Garments (AREA)
  • Ceramic Products (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Plant Substances (AREA)
ITMI911432A 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi IT1259419B (it)

Priority Applications (27)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
MYPI92000863A MY131089A (en) 1991-05-24 1992-05-20 Unsaturated 17(beta)-substituted 3-carboxy steroids
YU52992A YU52992A (sh) 1991-05-24 1992-05-20 Nezasićeni 17 beta-supstituisani 3-karboksi steroidi
US07/886,574 US5212166A (en) 1991-05-24 1992-05-21 Unsaturated 17β-subsituted 3-carboxy steroids
IL10194792A IL101947A (en) 1991-05-24 1992-05-21 Unsaturated 3-carboxy-steroids in 71-Transformed preparation and pharmaceutical preparations containing
NZ242850A NZ242850A (en) 1991-05-24 1992-05-21 17-carbamoyl androstane derivatives; medicaments, use, and methods of
EP92108670A EP0517047A1 (en) 1991-05-24 1992-05-22 Unsaturated 17beta-substituted 3-carboxy steroids
CA002087953A CA2087953A1 (en) 1991-05-24 1992-05-22 Unsaturated 17.beta. -substituted 3-carboxy steroids
AU17781/92A AU655280B2 (en) 1991-05-24 1992-05-22 Unsaturated 17beta -substituted 3-carboxy steroids
HU9300176A HUT64083A (en) 1991-05-24 1992-05-22 Process for producing unsaturated, 17beta-substituted 3-carboxy steroids and pharmaceutical compositions comprising same as active ingredient
JP50978992A JP3226919B2 (ja) 1991-05-24 1992-05-22 不飽和の１７β―置換―３―カルボキシステロイド
EP92910992A EP0540717B1 (en) 1991-05-24 1992-05-22 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS
DE69221074T DE69221074T2 (de) 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide
AT92910992T ATE155792T1 (de) 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide
DK92910992.4T DK0540717T3 (da) 1991-05-24 1992-05-22 Umættede 17 beta-substituerede 3-carboxysteroider
IDP308292A ID954B (id) 1991-05-24 1992-05-22 STEROID 3-KARBOKSI TERSUBSTITUSI-17β TAK JENUH
PCT/EP1992/001153 WO1992020700A1 (en) 1991-05-24 1992-05-22 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS
CZ93265A CZ281309B6 (cs) 1991-05-24 1992-05-22 Nenasycené 17beta-substituované 3-karboxy-steroidy
ES92910992T ES2106185T3 (es) 1991-05-24 1992-05-22 3-carboxiesteroides 17-beta-sustituidos no saturados.
RU93004939A RU2104283C1 (ru) 1991-05-24 1992-05-22 17бета-замещенные 3-карбоксистероиды, способ их получения, фармкомпозиция
MX9202438A MX9202438A (es) 1991-05-24 1992-05-22 Esteroides 3-carboxi insaturados substituidos en la posicion 17 beta, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ZA923758A ZA923758B (en) 1991-05-24 1992-05-22 Unsaturated 17-substituted 3-carboxy steroids
TW081104019A TW213467B (it) 1991-05-24 1992-05-22
CN92103919A CN1035055C (zh) 1991-05-24 1992-05-23 不饱和的17β-取代的3-羧基甾族化合物的制备方法
IE163492A IE921634A1 (en) 1991-05-24 1992-07-01 UNSATURATED 17ß-SUBSTITUTED 3-CARBOXY STEROIDS
FI930277A FI930277A (fi) 1991-05-24 1993-01-22 Omaettade 17b-substituerade 3-karboxisteroider
NO93930244A NO930244L (no) 1991-05-24 1993-01-25 Umettede 17beta-substituerte 3-karboksysteroider

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Publications (3)

Publication Number Publication Date
ITMI911432A0 ITMI911432A0 (it) 1991-05-24
ITMI911432A1 true ITMI911432A1 (it) 1992-11-24
IT1259419B IT1259419B (it) 1996-03-18

Family

ID=11359980

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Country Status (26)

Country Link
US (1) US5212166A (it)
EP (2) EP0517047A1 (it)
JP (1) JP3226919B2 (it)
CN (1) CN1035055C (it)
AT (1) ATE155792T1 (it)
AU (1) AU655280B2 (it)
CA (1) CA2087953A1 (it)
CZ (1) CZ281309B6 (it)
DE (1) DE69221074T2 (it)
DK (1) DK0540717T3 (it)
ES (1) ES2106185T3 (it)
FI (1) FI930277A (it)
HU (1) HUT64083A (it)
ID (1) ID954B (it)
IE (1) IE921634A1 (it)
IL (1) IL101947A (it)
IT (1) IT1259419B (it)
MX (1) MX9202438A (it)
MY (1) MY131089A (it)
NO (1) NO930244L (it)
NZ (1) NZ242850A (it)
RU (1) RU2104283C1 (it)
TW (1) TW213467B (it)
WO (1) WO1992020700A1 (it)
YU (1) YU52992A (it)
ZA (1) ZA923758B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022333A1 (en) * 1992-04-30 1993-11-11 Smithkline Beecham Corporation 17α AND 17β-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
AU7719894A (en) * 1993-09-03 1995-03-22 Smithkline Beecham Corporation Stabilized tablet formulation
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
US5430157A (en) * 1993-12-13 1995-07-04 Eli Lilly And Company Reduced phenanthrenes
GB9402041D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Corp Compounds
US5714480A (en) * 1994-03-31 1998-02-03 Smithkline Beecham Corporation Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
WO1995028413A1 (en) * 1994-04-15 1995-10-26 Smithkline Beecham Corporation 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
EP0725074A3 (en) * 1992-04-20 1996-11-20 Sankyo Co Compounds for use, therefore, intermediates for the preparation of androst-3,5-diene-3-carboxy derivatives

Also Published As

Publication number Publication date
DE69221074D1 (de) 1997-09-04
AU655280B2 (en) 1994-12-15
MY131089A (en) 2007-07-31
EP0540717B1 (en) 1997-07-23
IE921634A1 (en) 1992-12-02
IL101947A (en) 1996-01-19
JPH06500342A (ja) 1994-01-13
EP0540717A1 (en) 1993-05-12
CZ26593A3 (en) 1993-11-17
ZA923758B (en) 1993-01-27
CA2087953A1 (en) 1992-11-25
NO930244L (no) 1993-01-27
HU9300176D0 (en) 1993-04-28
NZ242850A (en) 1994-01-26
DK0540717T3 (da) 1997-08-18
HUT64083A (en) 1993-11-29
ITMI911432A0 (it) 1991-05-24
ID954B (id) 1996-09-25
YU52992A (sh) 1995-03-27
US5212166A (en) 1993-05-18
FI930277A0 (fi) 1993-01-22
CZ281309B6 (cs) 1996-08-14
WO1992020700A1 (en) 1992-11-26
MX9202438A (es) 1992-11-01
CN1035055C (zh) 1997-06-04
FI930277A (fi) 1993-01-22
JP3226919B2 (ja) 2001-11-12
CN1067057A (zh) 1992-12-16
DE69221074T2 (de) 1997-11-13
NO930244D0 (no) 1993-01-25
EP0517047A1 (en) 1992-12-09
RU2104283C1 (ru) 1998-02-10
IT1259419B (it) 1996-03-18
TW213467B (it) 1993-09-21
AU1778192A (en) 1992-12-30
ATE155792T1 (de) 1997-08-15
ES2106185T3 (es) 1997-11-01

Similar Documents

Publication Publication Date Title
ITMI911432A1 (it) Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 alfa reduttasi
BG102792A (en) Substituted derivatives of 4-hydroxyphenylalkane acids having antagonists activity to ppar-gama.
TR200002671T2 (tr) Bisiklo(2.2.1)Heptanlar ve ilgili bileşikler
FI865037A (fi) Mikrobicida kompositioner.
MY100846A (en) Fungicidal pyridyl imidates
NO980856L (no) Piperazinderivater og fremgangsmÕte for fremstilling derav
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
ES2164164T3 (es) Derivados de aminotetrazol utiles como inhibidores de oxido nitrico sintasa.
EP0665208A4 (it)
MY101849A (en) Improvements in or relating to cyanopyrazole herbicides.
CO4910142A1 (es) Compuestos de furano nitrona
ES2053764T3 (es) Agentes antiparasitarios.
IL111849A0 (en) Dithiocarbonimide derivative, fungicidal/insecticidal/acaricidal composition containing said derivative as active ingredient, intermediate for use in production of said derivative and process for producing said derivative from said intermediate
HUP0002075A2 (hu) Fungicid keverékek
HUP0101996A2 (hu) Szinergetikus fungicid hatóanyag keverék és alkalmazása
SE8504346D0 (sv) N-alkyl(en)-n-(o,o-disubstituerad tiofosforyl)-n',n'-disubstituerade glycinamider, sett att framstella dessa samt akaricid, insekticid och fungicid, innehallande dess foreningar som verksam bestandsdel
HUP0002077A2 (hu) Fungicid keverékek
IN185781B (it)
NZ512803A (en) Cyclic guanidine derivatives useful as pesticides
TH35014A (th) สารฆ่าวัชพืชประเภทเฮทอโรไซคลิค

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970506